News Frazier to stay on as Merck CEO, as company axes retirement ... Merck & Co’s CEO Ken Frazier has received the strongest possible backing from the company’s board, after it was announced the pharma company has rescinded a mandatory retirement age pol
News Pharma depriving developing countries of taxes - report A damning report by Oxfam claims that pharma giants are ‘depriving’ developing countries of millions of dollars' worth of tax money annually.
News Merck to file for new use for antibiotic Zerbaxa Antibiotic matched standard of care in phase 3 trial
News Eisai/Merck & Co's Lenvima approved in EU for first line liv... The European Commission has approved Eisai/Merck & Co's Lenvima as a new first-line treatment for liver cancer.
News Merck launches map4health diabetes mobile app App is result of 11-year collaboration with Healthy Interactions
News ADARx, Trex, and Retension take aim at IPOs The appetite among biotechs for IPOs shows no signs of being satisfied, with three more – ADARx, TRex, and Retension – making their intentions known.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.